Mei Wang

STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway

K. Hui, J. Xia, H. Xia, 2021, Theranostics.

STK 39 is a novel kinase contributing to the progression of hepatocellular 1 carcinoma by the PLK 1 / ERK signaling pathway 2

K. Hui, J. Xia, H. Xia, 2020 .

RhoJ facilitates angiogenesis in glioblastoma via JNK/VEGFR2 mediated activation of PAK and ERK signaling pathways

Min Qi, H. Xia, Bin Qi, 2022, International journal of biological sciences.

Rhoj Is a Novel Target for Progression and Invasion of Glioblastoma by Impairing Cytoskeleton Dynamics

H. Xia, Bin Qi, Hongjin Chen, 2020, Neurotherapeutics.

The advances in targeted therapy and immunotherapy for glioblastoma: Basic research and clinical trials

H. Xia, Bin Qi, Fubing Wu, 2018 .

Hepatic SIRT6 deficit promotes liver tumorigenesis in the mice models

J. Xia, H. Xia, Sha-sha Jiang, 2020, Genes & diseases.

Centromere protein F is identified as a novel therapeutic target by genomics profile and contributing to the progression of pancreatic cancer.

H. Xia, Xiaoming Wang, L. Lan, 2020, Genomics.